J&J to resume roll out of COVID-19 vaccine in Europe after regulatory reviewBusiness · 6:32 PM UTC
Johnson & Johnson (JNJ.N) said on Tuesday it will resume rolling out its COVID-19 vaccine in Europe after the region's medical regulator said the benefits of the shot outweigh the risk of very rare, potentially lethal blood clots.
United StatesChurch leaders call for Home Depot boycott over Georgia voting curbs
AfricaChad President Idriss Deby killed on frontline, son to take over
United StatesJurors in Chauvin trial deliberate; Biden hopes for ‘right verdict’
TechnologyApple targets remote workers with new iPad Pro, slim iMacs using own chips
United StatesAnalysis: Bumpy first weeks of Harris’ immigration role show challenges of the job
Middle EastEXCLUSIVE Why a U.S. hospital and oil company turned to facial recognition
BusinessEXCLUSIVE Fed Chair Powell says won’t allow ‘substantial’ overshoot of inflation target - April 8 letter to U.S. senator
United StatesWhite House says US will set 'a large cap soon' for refugees
White House spokeswoman Jen Psaki said on Tuesday the Biden administration expects to set "a large cap soon" for how many refugees it will accept in the remaining months of this fiscal year.